Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Prim Prev. 2017 Oct;38(5):481–494. doi: 10.1007/s10935-017-0483-6

Table 2.

Bivariate, gender-stratified associations with HCV disclosure

Characteristic Female (n=104) Male (n=139)
Crude OR 95% CI p value Crude OR 95% CI p value
Demographic
  Age (years) 0.92 (0.87, 0.98) 0.006** 1.00 (0.95, 1.04) 0.944
  White ---a ---a ---a 2.51 (0.79, 7.95) 0.118
  High school graduate 1.56 (0.65, 3.74) 0.317 0.65 (0.31, 1.33) 0.235
  Currently married 1.60 (0.49, 5.28) 0.441 1.49 (0.58, 3.84) 0.412
  Unemployed 1.10 (0.46, 2.61) 0.838 1.72 (0.82, 3.59) 0.152
Interpersonal
  Spends most of free time alone 0.56 (0.21, 1.54) 0.264 1.45 (0.68, 3.08) 0.336
  Social conflict 2.68 (0.57, 12.73) 0.214 0.35 (0.12, 1.00) 0.051
  Dependent on someone else for majority of support 0.93 (0.39, 2.23) 0.878 1.03 (0.46, 2.30) 0.944
Other characteristics
  Lifetime history of IDU 0.65 (0.13, 3.29) 0.606 0.21 (0.05, 0.96) 0.044*
  Lifetime history of drug treatmentb 0.38 (0.15, 0.97) 0.042* 0.34 (0.16, 0.71) 0.004**
  Time since testing HCV positive (years) 0.95 (0.85, 1.06) 0.325 1.03 (0.92, 1.14) 0.627

HCV=Hepatitis C virus; OR=Odds ratio; CI=Confidence interval

a

Quasi-complete separation of the data related to race occurred among females due to the association of the covariate with only one outcome, leading to an infinite parameter estimate.

b

Drug treatment includes methadone detoxification, methadone maintenance, Outpatient Drug Free, residential treatment, non-methadone detoxification, and 12-step programs (Alcoholics Anonymous/ Narcotics Anonymous)

*

p<0.05.

**

p<0.01.